Caseware UK (AP4) 2023.0.135 2023.0.135 The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false22023-05-01falseNo description of principal activitytrue2false 14054801 2024-04-30 14054801 2023-05-01 2024-04-30 14054801 2022-04-19 2023-04-30 14054801 c:Director1 2023-05-01 2024-04-30 14054801 2023-04-30 14054801 d:CurrentFinancialInstruments 2024-04-30 14054801 d:CurrentFinancialInstruments 2023-04-30 14054801 d:CurrentFinancialInstruments d:WithinOneYear 2024-04-30 14054801 d:CurrentFinancialInstruments d:WithinOneYear 2023-04-30 14054801 d:ShareCapital 2024-04-30 14054801 d:ShareCapital 2023-04-30 14054801 d:RetainedEarningsAccumulatedLosses 2024-04-30 14054801 d:RetainedEarningsAccumulatedLosses 2023-04-30 14054801 c:FRS102 2023-05-01 2024-04-30 14054801 c:AuditExempt-NoAccountantsReport 2023-05-01 2024-04-30 14054801 c:FullAccounts 2023-05-01 2024-04-30 14054801 c:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 14054801 e:PoundSterling 2023-05-01 2024-04-30 iso4217:GBP xbrli:pure
Company registration number: 14054801











SURREY KIDNEY CLINIC LIMITED
Unaudited
Financial statements
Information for filing with the registrar
For the Year Ended 30 April 2024

















Coveney Nicholls Limited
Chartered Accountants
The Old Wheel House
31/37 Church Street
Reigate
Surrey
UK
RH2 0AD

 
SURREY KIDNEY CLINIC LIMITED
Registered number:14054801

Statement of Financial Position
As at 30 April 2024

2024
2023
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
5,839
8,746

Cash at bank and in hand
 5 
19,596
1,572

  
25,435
10,318

Creditors: amounts falling due within one year
  
(5,536)
(5,307)

Net current assets
  
 
 
19,899
 
 
5,011

Total assets less current liabilities
  
19,899
5,011

  

Net assets
  
19,899
5,011


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
19,799
4,911

  
19,899
5,011


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 23 January 2025.




Dr Hugh Gallagher
Director

The notes on pages 2 to 4 form part of these financial statements.

Page 1

 
SURREY KIDNEY CLINIC LIMITED
 
 
Notes to the Financial Statements

For the Year Ended 30 April 2024

1.


General information

The company is a private company limited by shares, registered in England and Wales. The address of
the registered office is The Old Wheel House, 31-37 Church Street, Reigate, RH2 0AD, England.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.


 
2.4

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 2

 
SURREY KIDNEY CLINIC LIMITED
 
 
Notes to the Financial Statements

For the Year Ended 30 April 2024

2.Accounting policies (continued)

 
2.5

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.6

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.7

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees




The average monthly number of employees, including directors, during the year was 2 (2023 - 2).


4.


Debtors

2024
2023
£
£


Trade debtors
4,812
8,746

Prepayments and accrued income
1,027
-

5,839
8,746



5.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
19,596
1,572

19,596
1,572


Page 3

 
SURREY KIDNEY CLINIC LIMITED
 
 
Notes to the Financial Statements

For the Year Ended 30 April 2024

6.


Creditors: Amounts falling due within one year

2024
2023
£
£

Corporation tax
3,727
3,967

Other creditors
741
320

Accruals and deferred income
1,068
1,020

5,536
5,307



7.
Director's advances, credits and guarantees


2024

Balance brought forward 
Advances/
(credits) to the directors
Amounts repaid
Balance outstanding

£
£
£
£

Mr H & Mrs J Gallagher
(320)
2,521
(2,942)
(741)

2023

Balance brought forward 
Advances/(credits) to the directors
Amounts repaid
Balance outstanding

£
£
£
£

Mr H & Mrs J Gallagher
-
13,462
(13,782)
(320)


 
Page 4